These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

341 related items for PubMed ID: 12771005

  • 1. Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction.
    Kühl U, Pauschinger M, Schwimmbeck PL, Seeberg B, Lober C, Noutsias M, Poller W, Schultheiss HP.
    Circulation; 2003 Jun 10; 107(22):2793-8. PubMed ID: 12771005
    [Abstract] [Full Text] [Related]

  • 2. Viral persistence in the myocardium is associated with progressive cardiac dysfunction.
    Kühl U, Pauschinger M, Seeberg B, Lassner D, Noutsias M, Poller W, Schultheiss HP.
    Circulation; 2005 Sep 27; 112(13):1965-70. PubMed ID: 16172268
    [Abstract] [Full Text] [Related]

  • 3. High prevalence of viral genomes and multiple viral infections in the myocardium of adults with "idiopathic" left ventricular dysfunction.
    Kühl U, Pauschinger M, Noutsias M, Seeberg B, Bock T, Lassner D, Poller W, Kandolf R, Schultheiss HP.
    Circulation; 2005 Feb 22; 111(7):887-93. PubMed ID: 15699250
    [Abstract] [Full Text] [Related]

  • 4. Predictors of outcome in patients with suspected myocarditis.
    Kindermann I, Kindermann M, Kandolf R, Klingel K, Bültmann B, Müller T, Lindinger A, Böhm M.
    Circulation; 2008 Aug 05; 118(6):639-48. PubMed ID: 18645053
    [Abstract] [Full Text] [Related]

  • 5. High prevalence of cardiac parvovirus B19 infection in patients with isolated left ventricular diastolic dysfunction.
    Tschöpe C, Bock CT, Kasner M, Noutsias M, Westermann D, Schwimmbeck PL, Pauschinger M, Poller WC, Kühl U, Kandolf R, Schultheiss HP.
    Circulation; 2005 Feb 22; 111(7):879-86. PubMed ID: 15710767
    [Abstract] [Full Text] [Related]

  • 6. Myocardial biopsy based classification and treatment in patients with dilated cardiomyopathy.
    Zimmermann O, Kochs M, Zwaka TP, Kaya Z, Lepper PM, Bienek-Ziolkowski M, Hoher M, Hombach V, Torzewski J.
    Int J Cardiol; 2005 Sep 15; 104(1):92-100. PubMed ID: 16137516
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Detection of viral genome in the myocardium: lack of prognostic and functional relevance in patients with acute dilated cardiomyopathy.
    Kuethe F, Sigusch HH, Hilbig K, Tresselt C, Glück B, Egerer R, Figulla HR.
    Am Heart J; 2007 May 15; 153(5):850-8. PubMed ID: 17452164
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Beta-blocker improves survival, left ventricular function, and myocardial remodeling in hypertensive rats with diastolic heart failure.
    Kobayashi M, Machida N, Mitsuishi M, Yamane Y.
    Am J Hypertens; 2004 Dec 15; 17(12 Pt 1):1112-9. PubMed ID: 15607617
    [Abstract] [Full Text] [Related]

  • 17. The influence of growth hormone (GH) therapy on cardiac performance in patients with childhood onset GH deficiency.
    Minczykowski A, Gryczynska M, Ziemnicka K, Czepczynski R, Sowinski J, Wysocki H.
    Growth Horm IGF Res; 2005 Apr 15; 15(2):156-64. PubMed ID: 15809020
    [Abstract] [Full Text] [Related]

  • 18. Current insights into the pathogenesis, diagnosis and therapy of inflammatory cardiomyopathy.
    Noutsias M, Pauschinger M, Poller WC, Schultheiss HP, Kühl U.
    Heart Fail Monit; 2003 Apr 15; 3(4):127-35. PubMed ID: 12709733
    [Abstract] [Full Text] [Related]

  • 19. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.
    Daubert C, Gold MR, Abraham WT, Ghio S, Hassager C, Goode G, Szili-Török T, Linde C, REVERSE Study Group.
    J Am Coll Cardiol; 2009 Nov 10; 54(20):1837-46. PubMed ID: 19800193
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.